Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2024-02-09 00:00:00 ET · period of report 2024-02-07 · accession 0001562180-24-001214 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-09 | 2024-02-07 | SNDX | Legault Pierre | Dir | A - Grant | $0.00 | +17.0K | 65.0K | +35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | A | A | 17,000 | $0.00 | 65,000 | D | — | — | (F1) Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. |